中国血液净化

中国血液净化

• 血液净化中心管理与技术 • 上一篇    下一篇

浙江省维持性透析患者钙磷甲状旁腺激素水平调查

徐春萍     余碧影    杨 毅    张 萍     陈江华   

  • 收稿日期:2012-05-10 出版日期:2012-08-12 发布日期:2012-12-24

Serum calcium, phosphate, and iPTH levels of dialysis patients in Zhejiang Province

 Xu Chun-ping, Yu Bi-ying, Yang Yi, Zhang Ping, Chen Jiang-hua.   

  • Received:2012-05-10 Online:2012-08-12 Published:2012-12-24

RichHTML

0

PDF

165

摘要： 【摘要】目的调查2011年浙江省维持性透析患者的血清钙、磷、甲状旁腺激素水平。 方法  统计2011年浙江省血液透析和腹膜透析患者血清钙、磷、全段甲状旁腺激素的资料，根据肾脏病改善全球预后(Kidney Disease: Improving Global Outcomes, KDIGO)指南标准，分析患者的钙、磷、iPTH的达标率。 结果2011年浙江省维持性透析患者中，血液透析患者血清钙、磷、iPTH的达标率分别为58.1%、27.2%、56.3%，腹膜透析患者的达标率分别是71.1%、44.2%、65.6%。 结论 有相当比例的透析患者未能较好的控制血清钙、磷和iPTH水平，尤其是血磷的达标率更低，在血液透析患者中更加明显。

关键词: 血钙, 血磷, 甲状旁腺激素, 达标率, 维持性透析

Abstract: 【Abstract】 Objective To analyze serum calcium, phosphate, and intact parathyroid hormone (iPTH) levels of dialysis patients in Zhejiang Province in 2011.  Methods We collected these data from hemodialysis and peritoneal dialysis patients in Zhejiang Province in 2011. We then analyzed the compliance rate of serum calcium, phosphorus, iPTH according to the Kidney Disease: Improving Global Outcomes (KDIGO) guideline standards. Results The compliance rate of serum calcium, phosphorus and iPTH was 58.1%, 27.2% and 56.3%, respectively, in hemodialysis patients, and was 71.1%, 44.2% and 65.6%, respectively, in peritoneal dialysis patients. Conclusion Serum calcium, phosphorus and iPTH should be carefully monitored and controlled in dialysis patients, especially in hemodialysis patients.

Key words: Calcium, Phosphorus, Parathyroid hormone, Compliance rate, Maintenance dialysis